In other words, in patients presenting LVH there is a predominant stimulus for the synthesis of NT-proBNP which is cardiac wall stress [33], however, in patients without ventricular hypertrophy the peptide concentrations found in the bloodstream could be a consequence of diverse and variable physiological conditions [34]. The gene discussed is NPPB; the disease is cardiac hypertrophy.